Display search results for ** instead (39 products)
13 Jun 2012  |  Global
Move towards Preventative Care
This study provides overview of the Mega Trends that are likely to have an impact on the health and wellness of the patient world in 2020. The four interlinked scenariosgo green, digital backbone, personalised healthcare, and openness and transparency - have been discussed. These four have been shortlisted among the others because greener products...
USD 2,625.00 save 25 %
05 Oct 2018  |  North America
Companies are Vying for a Higher Market Position in the Early Cancer Screening Market
Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...
24 Aug 2018  |  North America
Optimizing Quality and Efficiency of Healthcare Delivery with AI
The study describes how AI technologies are paired with legacy healthcare IT systems to deal with the complexity & growth of medical data. Frost & Sullivan acknowledges that AI intuitively finds ways to convert these ever-expanding resources into actionable evidence for end users. In this study, Frost & Sullivan has forecast global revenue for prim...
26 Dec 2016  |  North America
Robot-based Hospital Automation and Augmented Quality of Care for Elderly and Disabled Offer High-yield, Early-stage Investment Opportunities for Firs
The global care assistance and automation robots market is expected to achieve rapid adoption with a CAGR of 36% through 2021. As doctors and care providers pay more attention to patients, leaving daily tasks for the efficient handling of robotic systems, patients will receive improved quality of care and reduced hospital readmission, the prime rea...
31 May 2017  |  Europe
Growth Opportunities in the European Next-generation Sequencing Informatics Market, Forecast to 2021
Big-data-driven Clinical Interpretation in Novel Areas is Set to Drive Market Growth
The cost of genomic sequencing has significantly declined in the recent past with the utilization of high-throughput sequencers creating opportunities for Next-generation Sequencing (NGS) informatics to develop genetic insights from the growing volume of sequencing data. As NGS technologies mature and the market stakeholders develop clarity on indu...
18 Jan 2017  |  North America
Strategies and Tactics for Accelerating Growth in a Transforming Market
Precision medicine aims to integrate personalized health data both from direct (quantifiable) and indirect (quantifiable) sources probing the deepest mysteries affecting individual health and well-being. Rising pressures to decrease healthcare cost globally, emergence of value-based reimbursement models, and healthcare digitization trends are trans...
29 Mar 2017  |  Europe
A Growing Number of Incentive Policies to Propel Growth in the Next 5–7 Years, with Oncology as the Fastest Adopter
Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...
02 Feb 2017  |  Europe
Exome and RNA Sequencing Focusing on Applied Markets to Drive Growth
The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: • Revenue Forecasts • Regional Market Dynamics • Market Share Analysis and Top Countries • Key Trends and Growth Opportunities • Game-chan...
30 Jun 2017  |  Europe
Data-driven Solutions and Co-development are Key Growth Drivers
The Western European Oncology Diagnostics Market, Forecast to 2021 study presents an overview of the oncology diagnostics market landscape in the Western European countries, with a focus on EU 5. The analysis provides forecasts for the EU 5 markets, segmented by types of cancer, which include breast cancer, ovarian cancer, cervical cancer, prostate...
06 Jul 2017  |  Asia Pacific
Innovation, Technology Integration, and New Customer Segments to Drive New Business Growth
There is high growth in the Asia-Pacific (APAC) oncology diagnostics market due to increasing incidence of cancer and the drastic reduction in incidence age owing to a plethora of reasons in the regional market. The major drivers for the APAC cancer diagnostics market are increase in adoption of technology platforms, access to targeted cancer thera...